Home
Conditions
Digestive System Neoplasms

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,377 public trials 3,276 recruiting studies

Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study

NCT01570010

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Akershus University Hospital Lørenskog, Norway

University of Oslo Oslo, Norway

Oslo University Hospital Oslo, Norway

View Trial Details

Active, not recruiting

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

NCT07457541

Conditions: Breast Cancer (Locally Advanced or Metastatic), Breast Diseases, Breast Neoplasms, +29 more
Locations: Tomsk National Research Medical Center of the Russian Academy of Sciences Tomsk, Tomsk Oblast, Russia

View Trial Details

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NCT05144854

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations: National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan

Kanagawa Cancer Center Yokohama, Kanagawa, Japan

Osaki Citizen Hospital Osaki-shi, Miyagi, Japan

Osaka University Hospital Suita-shi, Osaka, Japan

View all 57 locations

View Trial Details

Active, not recruiting

The French E3N Prospective Cohort Study

NCT03285230

Conditions: Asthma, Basal Ganglia Diseases, Behavior, +72 more
Locations: Villejuif, France

View Trial Details

Active, not recruiting

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

NCT05426005

Conditions: Colonic Diseases, Colorectal Cancer Stage IV, Colorectal Neoplasms, +13 more
Locations: The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.

NCT05497778

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

NCT04929392

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +31 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

NCT02156739

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer

NCT06783140

Conditions: BRCA1/2 Mutation, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, not recruiting

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

NCT04522544

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Universitätsklinikum Bonn Bonn, Germany

Universitätsklinikum Köln Cologne, Germany

Universitätsklinikum Essen Essen, Germany

Universitätsmedizin Göttingen Göttingen, Germany

View Trial Details

Digestive System Neoplasms

Digestive System Neoplasms trial results

Related conditions